When to Stop GLP-1 Medications Before Surgery: 2026 Anesthesia Guidelines Explained

A Routine Surgery That Almost Went Wrong

She'd followed every pre-surgery instruction perfectly. Nothing to eat after midnight. Arrived at 6 AM. What nobody asked about was the Ozempic injection she'd taken five days earlier.

During intubation, her anesthesiologist noticed something alarming—her stomach still contained food from dinner two nights ago. The surgery was canceled. She was lucky. Not everyone has been.

This scenario has played out in operating rooms worldwide as GLP-1 medications have exploded in popularity. These drugs do something remarkable for weight loss, but that same mechanism creates a genuine safety concern when you need to go under anesthesia.

Why GLP-1 Medications Create Surgical Risk

Here's what's actually happening in your body. GLP-1 receptor agonists—Ozempic, Wegovy, Mounjaro, and their relatives—work partly by slowing gastric emptying. Food stays in your stomach longer. You feel full. You eat less.

Brilliant for weight management. Potentially dangerous when you're lying unconscious on an operating table.

Anesthesia relaxes the muscle that normally keeps stomach contents from traveling upward. If there's food in your stomach, it can come up and enter your lungs. This is called pulmonary aspiration, and it can cause severe pneumonia, lung damage, or death.

The standard "nothing after midnight" rule assumes your stomach will be empty by morning. GLP-1 medications break that assumption entirely. Studies have found food remaining in patients' stomachs 24, 48, even 72 hours after their last meal while on these medications.

The 2026 Guidelines: What's Actually Recommended

The American Society of Anesthesiologists updated their guidance in late 2024, and additional refinements came through 2025. Here's where things stand now.

For weekly injectables like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), the recommendation is to hold the medication for at least 7 days before elective surgery. Some practitioners extend this to 14 days for patients on higher doses or those reporting significant GI symptoms.

Daily medications like liraglutide (Saxenda, Victoza) should be stopped at least 24 hours before surgery. The shorter half-life makes the timeline more manageable.

But here's what makes this complicated: these are guidelines, not absolute rules. Your surgical team needs to weigh aspiration risk against the risks of delaying your procedure.

The Dose and Duration Factor

Not all GLP-1 patients face equal risk. Someone who started Ozempic two weeks ago at the lowest dose has a very different gastric emptying profile than someone who's been on maximum-dose Mounjaro for eighteen months.

A 2024 analysis published in Anesthesiology found that patients on GLP-1 therapy for more than 6 months showed more pronounced delayed gastric emptying compared to newer users. Higher doses correlated with longer food retention times.

This means the one-week guideline might be insufficient for long-term, high-dose users. Some anesthesiologists are now recommending 2-3 week holds for this population, particularly before procedures requiring deep sedation.

Your prescribing physician and surgical team should discuss your specific situation. Blanket protocols don't capture individual variation.

What Happens When Surgery Can't Wait

Elective procedures can be rescheduled. Emergency surgery cannot.

If you need urgent surgery while on GLP-1 medication, your anesthesia team has several options. They can perform a gastric ultrasound to actually visualize stomach contents—this takes about two minutes and shows whether you have significant residual food or liquid.

If the stomach isn't empty, they might proceed using "full stomach precautions." This typically means rapid sequence intubation, a technique that minimizes the window during which aspiration could occur. It's not risk-free, but it's far safer than standard induction in a patient with gastric contents.

Another option is regional anesthesia when appropriate for the procedure. A spinal block for a leg surgery, for instance, doesn't require airway management and eliminates aspiration risk entirely.

The key point: urgent surgery on GLP-1 patients is absolutely possible. It just requires modified protocols and explicit communication with your anesthesia team.

The Pre-Surgery Conversation You Need to Have

Here's what frustrates anesthesiologists: patients don't always disclose GLP-1 use. Sometimes they forget. Sometimes they don't realize it matters. Sometimes they're embarrassed about taking weight loss medication.

In a 2024 survey of anesthesiology practices, 34% of respondents reported encountering patients who hadn't disclosed GLP-1 use during pre-operative assessment. That number is likely an undercount.

When you have your pre-surgical consultation, explicitly mention any GLP-1 medication. Include the exact name, your current dose, when you started it, and when you took your last dose. If you've already stopped it in preparation for surgery, mention that too.

This information should appear in your chart, but redundancy saves lives. Tell the nurse. Tell the anesthesiologist. Tell anyone who asks about your medications.

GI Symptoms as a Warning Sign

The guidelines include an important qualifier: patients experiencing active GI symptoms deserve extra caution regardless of when they stopped their medication.

Nausea, vomiting, bloating, abdominal distension, or severe acid reflux in the days before surgery suggest your stomach may not be emptying normally. These symptoms should prompt consideration of delaying elective procedures or using point-of-care gastric ultrasound to assess stomach contents.

One practical approach some surgical centers have adopted: calling patients 24-48 hours before their procedure specifically to ask about GI symptoms. This simple check has caught cases that would otherwise have been discovered only in the operating room.

The Diabetes Consideration

Many GLP-1 users take these medications for type 2 diabetes, not weight management. This creates an additional layer of complexity.

Stopping diabetes medication for a week or more can lead to hyperglycemia. Elevated blood sugar impairs wound healing, increases infection risk, and can cause its own surgical complications.

For diabetic patients, the pre-operative period often requires a temporary switch to alternative glucose management. This might mean short-acting insulin, other oral medications, or simply more frequent blood sugar monitoring with as-needed intervention.

The key is planning. A week before surgery is not the time to figure this out. These conversations should happen during your initial surgical consultation, giving everyone time to coordinate care between your surgeon, anesthesiologist, and diabetes management team.

What About Procedures Under Sedation?

Not all procedures require general anesthesia. Colonoscopies, certain dental procedures, and minor surgeries often use moderate sedation—you're drowsy but not completely unconscious.

The aspiration risk exists here too, though it's somewhat lower. Current guidance suggests applying similar hold periods for procedures requiring any level of sedation that might impair protective airway reflexes.

Endoscopy centers have been particularly affected by this issue. A 2024 report noted a significant increase in procedure cancellations related to GLP-1 use. Many facilities now include specific GLP-1 questions in their pre-procedure screening and have implemented standardized hold protocols.

If you're scheduled for any procedure involving sedation, ask specifically about GLP-1 guidelines. Don't assume that "minor" sedation means the medication doesn't matter.

Looking Ahead: Better Solutions Coming

The medical community recognizes that current guidelines are somewhat blunt instruments. Telling everyone to stop their medication for a week doesn't account for individual variation in gastric emptying.

Research is underway on several fronts. Point-of-care gastric ultrasound is becoming more widespread, allowing real-time assessment rather than arbitrary timelines. Some centers are exploring prokinetic agents—medications that speed gastric emptying—as a bridge for patients who can't safely stop GLP-1 therapy.

There's also growing interest in identifying which patients actually have significantly delayed emptying versus those whose gastric function remains relatively normal despite GLP-1 use. Biomarkers or simple clinical predictors could eventually allow more personalized recommendations.

For now, though, the conservative approach prevails. When the stakes include aspiration pneumonia, erring on the side of caution makes sense.

Your Pre-Surgery Checklist

Practical steps if you're on GLP-1 medication and have upcoming surgery:

Contact your surgical team as soon as the procedure is scheduled. Don't wait for the pre-op appointment.

Ask specifically about their GLP-1 protocol. Policies vary between institutions and even between individual practitioners.

Coordinate with whoever prescribes your GLP-1. They need to know about the surgery and may need to adjust your overall treatment plan.

Document when you take your last dose. Write it down. You'll be asked multiple times.

Report any GI symptoms in the days before surgery, even if they seem minor.

On the day of surgery, remind your anesthesia team about your GLP-1 history, even if it's in your chart.

The goal isn't to create anxiety about a routine aspect of these medications. Millions of people on GLP-1 therapy have surgery every year without incident. But those good outcomes happen because of proper preparation and communication, not despite the medication's effects.